Jane Street
EWTX icon

Jane Street’s Edgewise Therapeutics EWTX Stock Holding History

Jane Street’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
+35,578
New +$1.03M ﹤0.01% 6254
2025
Q4 		– Sell
-69,998
Closed -$1.41M – 11471
2025
Q3 		$1.14M Buy
69,998
+19,813
+39% +$281K ﹤0.01% 6041
2025
Q2 		$658K Buy
50,185
+35,427
+240% +$511K ﹤0.01% 6432
2025
Q1 		$325K Sell
14,758
-15,800
-52% -$414K ﹤0.01% 7667
2024
Q4 		$816K Sell
30,558
-19,812
-39% -$631K ﹤0.01% 5768
2024
Q3 		$1.34M Sell
50,370
-14,117
-22% -$281K ﹤0.01% 5278
2024
Q2 		$1.16M Buy
64,487
+37,341
+138% +$651K ﹤0.01% 5493
2024
Q1 		$495K Sell
27,146
-16,993
-38% -$270K ﹤0.01% 6679
2023
Q4 		$483K Buy
+44,139
New +$310K ﹤0.01% 6818
2023
Q3 		– Sell
-15,438
Closed -$120K – 8829
2023
Q2 		$120K Sell
15,438
-16,215
-51% -$137K ﹤0.01% 7930
2023
Q1 		$211K Sell
31,653
-224
-0.7% -$2.08K ﹤0.01% 7765
2022
Q4 		$285K Buy
31,877
+13,288
+71% +$125K ﹤0.01% 7105
2022
Q3 		$183K Buy
18,589
+7,084
+62% +$71.6K ﹤0.01% 8254
2022
Q2 		$92K Buy
+11,505
New +$87K ﹤0.01% 8681

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street's EWTX Position: Q1 2026 in Review

Jane Street opened a new position in Edgewise Therapeutics (EWTX) in Q1 2026: 35,578 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #6254 among its holdings. This is a return to the name: Jane Street previously reported a position in EWTX as recently as Q3 2025.

Jane Street first reported a position in EWTX in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.34M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Jane Street held 35,578 shares of Edgewise Therapeutics worth $1.12M as of Q1 2026.
  • Edgewise Therapeutics was a new Jane Street position in Q1 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6254 holding.
  • Jane Street first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Jane Street's Edgewise Therapeutics position peaked at $1.34M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.